Although basal cells are known to function as human airway epithelial stem cells, analysis of these cells has been limited by in vitro culture techniques that only permit minimal cell growth and differentiation. Here, we report a protocol that dramatically increases the longterm expansion of primary human airway basal cells while maintaining their genomic stability using 3T3-J2 fibroblast co-culture and ROCK inhibition using Y-27632. We also describe techniques for the differentiation and immunofluorescence imaging of these expanded airway stem cells as three-dimensional tracheospheres containing basal, ciliated and mucosecretory cells. This 3D procedure allows investigation of the proximal airway epithelium under more physiologically relevant conditions than those found in traditional monolayer cultures. Together these methods represent a novel platform for improved airway stem cell growth and differentiation that is compatible with high throughput, high content translational lung research as well as human airway tissue engineering and clinical cellular therapy.
Introduction
Human airways represent a key environmental barrier whose dysregulation in diseases such as asthma, COPD, cystic fibrosis and cancer is a major cause of worldwide morbidity and mortality (1) . Human airways are composed of a pseudostratified ciliated and mucosecretory epithelium responsible for protecting against inhaled particulate matter, pathogens, and other airborne toxicants. Supporting this epithelium are multipotent basal stem cells characterized primarily by cytokeratin 5 (CK5) and P63 expression (2, 3) . Given the clear physiological importance of maintaining human airway homeostasis, establishing techniques for investigating basal stem cell growth and differentiation is of significant basic and translational relevance (4) .
Historically, the majority of airway stem cell research has involved studies of animal models that exhibit only limited human translational relevance (1) . To overcome this, researchers have traditionally used human air-liquid interface (ALI) cultures in which a confluent monolayer of human airway basal cells is cultured in medium containing retinoic acid and grown at an air interface to encourage ciliated and mucosecretory cell differentiation (5, 6) .
Despite the human biological relevance of these ALI models (7) , they remain extremely timeconsuming and poorly suited to high throughput, high content translational medicine approaches. In addition, evidence suggests that airway basal stem cells rapidly lose their capacity for multipotent differentiation and undergo premature senescence after only a small number of passages. This failure to maintain airway epithelial stem cells in vitro presents a considerable barrier for their use in translational medicine.
In this chapter, we describe a protocol for improved human airway stem cell expansion that maintains their multipotent differentiation capacity. Originally developed for epidermal keratinocyte stem cells, this technique relies upon the co-culture of primary human epithelial cells with mitotically inactivated 3T3-J2 fibroblast feeder cells (8) . Epithelial and J2 feeder cell co-cultures are grown in medium containing the Rho-associated kinase (ROCK) inhibitor Y-27632 (9) (10) (11) . Successful application of this procedure to airway epithelial cells provides large numbers of basal cells that exhibit physiologically relevant differentiation, karyotype stability and maintenance of telomere length (12) . In addition, we also provide methods for the differentiation and visualization of human airway basal cells as 3D airway tracheospheres. These techniques build on previous 3D culture systems in which either ciliated or mucosecretory differentiation was achieved (2, 13, 14) . The method described here, based on several recently published studies, permits normal ciliated and mucosecretory cell differentiation (12, 15, 16) and is compatible with high-throughput, highcontent analyses. Together these methods provide a platform to expand large numbers of airway basal epithelial cells from patient endobronchial biopsy samples and differentiate them in a 3D tracheosphere assay with potential applications in translational medicine, tissue engineering and cellular therapy approaches. 
3D Human Tracheospheres
1. Matrigel, basement membrane matrix, growth factor reduced (BD Biosciences; see 
Immunofluorescence Staining of Tracheospheres
Heat to 65°C to dissolve and adjust pH to 7.2.
Methods

Preparation of 3T3-J2 Feeder Layers
1. Maintain 3T3-J2 cells at low passage numbers (see Note 6) and maintain them subconfluent (see Note 7) in 37°C, 5% CO 2 incubators with weekly splits of 1:8-1:10.
2. For feeder layer preparation, add mitomycin C (4 μg/ml; final concentration) to flasks of 3T3-J2 cells in fibroblast culture medium for 2 hours (see Note 8).
3. Wash cells with PBS, harvest cells with 0.05% trypsin-EDTA and replate at a density of at least 20,000 feeder cells/cm 2 in fibroblast culture medium (see Note 9).
4. Allow 3T3-J2 cells to adhere and spread overnight before adding epithelial cells the following day (see Note 10).
Isolation of Human Airway Epithelial Cells
1. Derivation of human cells should be approved by the relevant local ethics committee.
2. Human airway epithelial cells are derived from brushings or biopsies taken during bronchoscopy procedures. Samples are transported to the laboratory on ice as soon as possible.
Cell seeding from brushings
1. Brushes are collected in 15 ml falcon tubes in transport medium.
Thoroughly vortex tubes to remove cells from the brush.
3. Centrifuge tubes, with brushes inside, at 300 xg for 5 minutes.
4. Carefully remove transport medium and resuspend the cell pellet in epithelial culture medium (see Note 11).
Seed cell suspension on pre-prepared T25 feeder layers, incubate at 37°C
(5% CO 2 ) and change the medium after two days. 6 . Epithelial colonies become evident after 2-3 days (see Note 12).
Cell seeding from biopsies
1. For explant cultures, biopsies are seeded directly onto pre-prepared feeder layers with a minimal covering of epithelial culture medium ( Figure  1A ; see Note 13) or they can be digested to form a cell suspension prior to culture.
2. To digest a biopsy, carefully transfer the biopsy to an eppendorf tube containing 16 U/ml dispase in RPMI. Digest for 20 minutes at room temperature.
3. Neutralize the digestion by adding an equal volume of neutralization medium.
4.
Transfer the tissue to a sterile petri dish and dissect away epithelium (see 10. Seed cell suspension on pre-prepared T25 feeder layers, incubate at 37°C (5% CO 2 ) and change the medium after two days. 11. Epithelial colonies become evident after 2-3 days.
Maintenance of Human Airway Basal Epithelial Cells
1. During normal maintenance epithelial cells are fed with fresh complete epithelial medium three times per week (10 ml per T75 or equivalent for other vessel surface areas) and stored in 37°C, 5% CO 2 incubators. Figure 1B ).
Passage epithelial cell cultures at 80-90% confluence (
Remove epithelial culture medium and wash cells once with PBS.
4. Add 0.05% trypsin-EDTA (see Note 15) for 2 minutes at room temperature, gently tap flasks and confirm the removal of feeder cells, which are substantially more trypsinsensitive than epithelial cells, under a microscope.
5.
Remove the trypsin and wash with PBS to remove remaining feeder cells.
6. Add 0.05% trypsin-EDTA and incubate at 37°C until epithelial cells detach from the flask (typically this takes 5 minutes; see Note 16).
7. Neutralize the trypsin solution with the same volume of epithelial culture medium, centrifuge at 300 xg for 5 minutes and resuspend the pellet in epithelial culture medium.
8. For continued passage, perform a 1:5 split and seed cells onto a pre-prepared feeder layer in complete epithelial culture medium. Incubate in a 37°C, 5% CO 2 incubator. 9. To cryopreserve, freeze 0.5 x 10 6 cells/vial in 200 μl total volume using Profreeze freezing medium according to the manufacturer's instructions.
3D Tracheosphere Culture
1. Coat the base of a non-adherent 96-well plate with 25% pre-chilled Matrigel in tracheosphere medium (30 μl per well) and transfer to an incubator (37°C, 5% CO 2 ) for at least 20 minutes (see Note 17). 2. Using the same centrifuge settings, wash once with PBS and resuspend the tracheosphere pellet in pre-warmed HistoGel specimen processing gel. Pipette the HistoGel onto parafilm as small droplets appropriate for embedding and allow it to gel at room temperature for 10 minutes.
Differentially trypsinize cultured airway basal cells from feeder cells as described
Immunofluorescence Staining of Tracheospheres
3. Process, embed and stain the tracheospheres according to standard histology protocols ( Figure 2B-D) .
Notes
1) Batch testing of FBS for the ability to support rapid expansion and serial passage of primary human epithelial cells is essential.
2) Hydrocortisone/EGF stock is prepared by dissolving hydrocortisone at 0.5 mg/ml in 100% ethanol. 1 ml hydrocortisone is added to 19 ml DMEM containing 2.5 μg recombinant human EGF. Hydrocortisone/EGF stock aliquots are stored at -20°C.
3) A bottle of Matrigel must be thawed on ice for >6 hours. Once thawed, Matrigel should be aliquoted into pre-chilled, sterile eppendorf tubes and stored at -20°C.
Freeze-thaw Matrigel a maximum of three times. Matrigel should be kept on ice throughout the tracheosphere seeding process. 4) Retinoic acid is extremely light sensitive. Care should be taken to minimize light exposure during preparation and storage, for example by foil wrapping falcon tubes.
Aliquotted 10 mM stocks can be stored for up to one month at -80°C. We prepare a 1:1000 (10 μM) stock and dilute this 1:100 to prepare tracheosphere medium (final conc. 100 nM). 5) A 10 ml vial of HistoGel should be pre-heated to 65°C in a waterbath for 30 minutes.
HistoGel can be aliquoted into 1.5 ml eppendorf tubes to reduce this time to 10 minutes and sets quickly at room temperature so should be kept at 65°C until use.
6)
We thaw fresh 3T3-J2 cells after passage 12 as the cells are susceptible to undergoing spontaneous transformation, proliferating more rapidly and adopting a cuboidal morphology compared with the usual spread appearance of fibroblasts. 7) 3T3-J2 cultures should never be allowed to become over confluent as their morphology and sensitivity to irradiation/mitomycin C can be affected, leading to poor quality feeder layers. 8) Alternatively, 3T3-J2s can be mitotically inactivated by 40 Gy (4000 rd) irradiation. 9) After mitotic inactivation, 3T3-J2 cells are fragile and care should be taken when pipetting the cells as excessive stress can cause feeder layers to degenerate more rapidly.
10) Co-seeding of 3T3-J2 and epithelial cells in complete epithelial culture medium produces poor quality feeder layers. Mitotically inactivated fibroblasts do not spread, as when seeded in fibroblast culture medium, and feeder layers degenerate more quickly. Thus, it is important to be well-organized in the planning of experiments using co-cultured cells. 11) Care should be taken to wash the brush with epithelial culture medium to free as many cells as possible. We use at least two rounds of washing with fresh medium. 12) Contamination of cultures with human fibroblasts has not been a problem in our lab.
It is thought that the combination of the feeder layers and culture medium additives suppress the growth of fibroblasts.
13)
We do not change the medium on explant biopsies for the first 7 days of culture in order to avoid the risk of detaching the biopsy by moving the flask. Epithelial outgrowths are normally visible in the second week and can be serially passaged as described in Step 3.3.3.
14)
In practice, it is difficult to see the epithelium at this stage -after proper dispase digest the biopsy will appear 'fluffy' -but we do find that pulling apart the biopsy at this stage improves the efficiency of the trypsin step. 15 ) TrypLE Select (Gibco, Thermo Fisher), a recombinant trypsin that avoids the use of porcine trypsin in human cultures, can be used in place of 0.05% Trysin-EDTA for passaging epithelial cells with no negative impact on the quality of cultures. 16 ) Epithelial cells should be treated with care during passaging. We remove cells following trypsinization by gently tapping flasks rather than by washing. Care should also be taken to avoid excessive pipetting of epithelial cells during resuspension. 17) To maximize the well volume available for addition of culture medium, the Matrigel layer at the well base is minimal. Non-adherent culture plates are used to prevent cells in close proximity to the culture plastic from losing 3D structure.
18) Video microscopy studies indicate that tracheospheres formed from cells at this density are not clonal but multiple basal cells in the initial culture can migrate and interact to form tracheospheres.
19)
Tracheospheres are very sensitive to culture conditions. We use dedicated incubators, with extra humidification, for airway differentiation assays in order to reduce the number of times incubator doors are opened and to better maintain constant humidity, CO 2 , etc.
20) The abundance of cilia in tracheospheres increases over time. Cilia are observed at day 14 but longer culture periods produce better results. This must be balanced with the ability to continue to add culture medium to wells. End-point assays can be performed between day 14 and day 21. 
